Active, not recruitingNCT07158190

Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).

Studying Dengue fever

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Principal Investigator
Carlo Torti, Prof
Fondazione Policlinico Agostino Gemelli IRCCS
Intervention
Vaccine(biological)
Enrollment
30 enrolled
Eligibility
18-65 years · All sexes
Timeline
20242025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07158190 on ClinicalTrials.gov

Other trials for Dengue fever

Additional recruiting or active studies for the same condition.

See all trials for Dengue fever

← Back to all trials